Brush Up on Biosimilars

January 2025

You’ll see more Rxs for biosimilars...now that there are over 60 available in Canada. And around 10 were approved in 2024 alone.

For example, there are now several biosimilars approved for ustekinumab (Stelara)...with Pyzchiva and Steqeyma being the latest.

Keep in mind, biosimilars aren’t generics. It’s not possible to create an exact copy of the original reference product...since biologics contain larger, more complex molecules than most traditional drugs.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Biosimilars Brush Up on Biosimilars
Dermatology Know Where Topical Ruxolitinib Fits for Vitiligo and Eczema
Men's Health Prepare for a New Formulation of Sildenafil
Obesity & Weight Loss Watch for Med Changes After Bariatric Surgery
Acne Expect Questions About Sexual Dysfunction and Isotretinoin
Interactions Should Patients Still Avoid Grapefruit Juice With Statins?
Education and Training Use Strategies to Train Gen Z Learners
NatMed Spotlight Put Claims About Bovine Colostrum in Perspective

Brush Up on Biosimilars

Practical advice for a better career, with unlimited access to CE

Table of Contents